TortsProf Blog

Editor: Christopher J. Robinette
Widener Univ. School of Law

A Member of the Law Professor Blogs Network

Thursday, October 4, 2007

Stent Safety & Patents

The NYT has a piece today on the prolific patent litigation among stent manufacturers.  (Indeed, the longest trial I saw while clerking was a patent trial over stents.)  It leads with an interesting anecdote:

Why would a company argue in court that its medical product is dangerous, even as it plays down the risks in public?

Johnson & Johnson did just that recently as part of its long battle for supremacy in cardiac stents. Its lawyers told a federal judge in Delaware that because medical studies had linked the company’s drug-coated Cypher stent to blood clots, it could not have infringed a competitor’s patent.

How so? Because, the lawyers said, the patent in question, held by Boston Scientific, claimed that the coating did not cause clots.

That reasoning — in essence, our product isn’t covered by Boston Scientific’s patent because our product is a health hazard — did not impress Judge Sue L. Robinson, who last week affirmed a jury’s patent infringement verdict against the Cypher.

--BC

http://lawprofessors.typepad.com/tortsprof/2007/10/stent-safety-pa.html

Products Liability | Permalink

TrackBack URL for this entry:

http://www.typepad.com/services/trackback/6a00d8341bfae553ef00e54ef0175e8833

Listed below are links to weblogs that reference Stent Safety & Patents:

Comments

Post a comment